Author:
Uruno Akira,Noguchi Naoya,Matsuda Ken,Nata Koji,Yoshikawa Takeo,Chikamatsu Youichiro,Kagechika Hiroyuki,Harigae Hideo,Ito Sadayoshi,Okamoto Hiroshi,Sugawara Akira
Funder
Ministry of Health, Labor, and Welfare of Japan
Takeda Science Foundation
21st Century Centers of Excellence (COE) Program
Ministry of Education, Culture, Sports, Science and Technology
Subject
Cell Biology,Immunology,Immunology and Allergy
Reference51 articles.
1. CD38 as a therapeutic target;Stevenson;Mol. Med.,2006
2. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology;Malavasi;Physiol. Rev.,2008
3. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation;Jackson;J. Immunol.,1990
4. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member;Deaglio;J. Immunol.,1998
5. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-α;Drach;Cancer Res.,1994